Vidakem Lifesciences Pvt Ltd
Gliclazide (80mg) + Metformin (500mg)
Vidzid M 80mg/500mg Tablet is a combination of two medicines used to treat type 2 diabetes mellitus in adults. It helps control blood sugar levels in people with diabetes.
Tablet
Vidzid M 80mg/500mg Tablet belongs to a category of medicines known as anti-diabetic drugs. It is a combination of two medicines used to treat type 2 diabetes mellitus in adults. It helps control blood sugar levels in people with diabetes.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Vidzid M 80mg/500mg Tablet is to be taken with food.
No common side effects listed.
It is unsafe to consume alcohol with Vidzid M 80mg/500mg Tablet.
Vidzid M 80mg/500mg Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Vidzid M 80mg/500mg Tablet is unsafe to use during pregnancy as there is definite evidence of risk to the developing baby. However, the doctor may rarely prescribe it in some life-threatening situations if the benefits are more than the potential risks. Please consult your doctor.
Vidzid M 80mg/500mg Tablet is a combination of two antidiabetic medicines: Gliclazide and Metformin.
Monitor your blood sugar level regularly while you are taking this medicine. It can cause hypoglycemia (low blood sugar level) when used with other antidiabetic medicines, alcohol or if you delay or miss a meal. Inform your doctor about your diabetes treatment if you are due to have surgery under a general anesthetic. Tell your doctor immediately if you experience any deep or rapid breathing or if you have persistent nausea, vomiting, and stomach pain as Vidzid M 80mg/500mg Tablet may cause a rare but serious condition called lactic acidosis.
Vidzid M 80mg/500mg Tablet contains two active ingredients: Gliclazide and Metformin. This medicine is used for the treatment of type 2 diabetes mellitus (DM). It helps regulate blood glucose levels in adults when combined with a healthy diet and exercise regimen. Gliclazide increases insulin release from the pancreas, while Metformin reduces glucose production by the liver, improving insulin sensitivity.
Common side effects include hypoglycemia (low blood sugar), altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory tract infections. In rare cases, Vidzid M 80mg/500mg can lead to serious complications like lactic acidosis.
Yes, the use of Vidzid M 80mg/500mg Tablet can lead to hypoglycemia. Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, fast heart rate, and feeling anxious or shaky. It is important to monitor blood sugar levels regularly.
Yes, the use of Vidzid M 80mg/500mg Tablet can lead to lactic acidosis. It is a rare but serious side effect that needs immediate medical attention if detected.
Yes, long-term use of Vidzid M 80mg/500mg Tablet can lead to vitamin B12 deficiency. This happens because the medication interferes with the absorption of Vitamin B12 in the stomach. Untreated, this may result in anemia and nerve problems, including tingling sensations, weakness, urinary issues, changes in mental status, and difficulty maintaining balance.
It is advised to avoid Vidzid M 80mg/500mg Tablet if you have allergies to the active ingredients or excipients. In addition, individuals with severe kidney disease, underlying metabolic acidosis, including diabetic ketoacidosis, and other conditions that might exacerbate these side effects should consult a healthcare professional.
No, combining alcohol with Vidzid M 80mg/500mg Tablet is not recommended. This could lower blood sugar levels and increase the risk of lactic acidosis.